LHDX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 Mar 2023 @ 16:00):

Stats
Today's Volume	36.26M
Average Volume	21.45M
Market Cap	18.36M
EPS	$0 ( 2023-05-10 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.144
ATR14	$0.0630 (13.93%)

Insider Trading

Date	Person	Action	Amount	type
2023-03-03	Engelson Erik T.	Buy	574 666	Common Stock
2023-03-03	Engelson Erik T.	Sell	574 666	Common Stock
2023-03-03	Engelson Erik T.	Sell	60 000	Common Stock
2023-03-03	Engelson Erik T.	Sell	574 666	Common Stock
2023-03-03	Narido Richard Clavano	Sell	10 674	Common Stock

INSIDER POWER
-77.72
Last 96 transactions
Buy: 17 602 742 \| Sell: 22 464 128

Volume Correlation

Long: 0.09 (neutral)

Short: 0.47 (neutral)

Signal:(52.543) Neutral

Lucira Health, Inc. Correlation

10 Most Positive Correlations
XPDI	0.906
GOODM	0.898
FATE	0.897
PIII	0.889
SMIT	0.884
MGPI	0.882
PROC	0.872
HECCU	0.871
ODT	0.871
EYEG	0.867

10 Most Negative Correlations
IPVI	-0.899
IQ	-0.889
FRGI	-0.887
CCRC	-0.876
TIG	-0.869
CTIB	-0.868
XFIN	-0.866
STAY	-0.865
DSPG	-0.863
BTWN	-0.86

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Lucira Health, Inc. Correlation - Currency/Commodity

-0.47
( neutral )

-0.41
( neutral )

0.00
( neutral )

-0.04
( neutral )

-0.57
( weak negative )

0.53
( weak )

Lucira Health, Inc. Financials

Annual	2021
Revenue:	$93.06M
Gross Profit:	$10.22M (10.99 %)
EPS:	$-1.807

Q3	2022
Revenue:	$34.39M
Gross Profit:	$-99.56M (-289.49 %)
EPS:	$-3.15

Q2	2022
Revenue:	$26.15M
Gross Profit:	$7.99M (30.57 %)
EPS:	$-0.540

Q1	2022
Revenue:	$90.47M
Gross Profit:	$39.92M (44.12 %)
EPS:	$0.310

Financial Reports:

No articles found.

Lucira Health, Inc.

Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California.